HomePPBT • NASDAQ
Purple Biotech Ltd - ADR
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.41M | -68.52% |
Net income | -453.00K | 87.96% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.36M | 69.19% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.09M | -34.71% |
Total assets | 35.59M | -10.71% |
Total liabilities | 2.90M | -66.96% |
Total equity | 32.70M | — |
Shares outstanding | 526.45M | — |
Price to book | 40.40 | — |
Return on assets | -9.68% | — |
Return on capital | -10.66% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -453.00K | 87.96% |
Cash from operations | -1.98M | 61.08% |
Cash from investing | 257.00K | -17.63% |
Cash from financing | 103.00K | -61.57% |
Net change in cash | -1.63M | 63.83% |
Free cash flow | -1.99M | -49.50% |
Previous close
$2.42
Day range
$2.33 - $2.46
Year range
$2.00 - $13.95
Market cap
6.84M USD
Avg Volume
30.76K
About
Founded
1968
Website
Employees
9
